Hair Growth Supplement and Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Hair Growth Supplement and Treatment Market is projected to expand from USD 7.65 Billion in 2025 to USD 11.12 Billion by 2031, reflecting a compound annual growth rate of 6.43%. This market sector comprises a wide variety of therapeutic devices, dietary supplements, and pharmaceutical formulations aimed at enhancing scalp health and stimulating hair follicles. Key growth drivers include a globally aging demographic increasingly prone to androgenetic alopecia, alongside a growing psychological focus on personal aesthetics that encourages individuals to pursue restorative treatments earlier in the thinning process. Additionally, shifting dietary patterns and rising stress levels have widened the potential consumer base, creating a need for effective remedies that extend beyond traditional user groups.

Recent industry data highlights a strong consumer dedication to maintaining aesthetic vitality. For instance, the Council for Responsible Nutrition reported that in 2024, 26% of dietary supplement users in the United States consumed products specifically meant to support the health of skin, hair, and nails. Despite this persistent demand, the market faces substantial obstacles due to rigorous regulatory standards for new pharmaceutical agents. These stringent requirements can extend approval timelines significantly, thereby slowing the commercialization of innovative clinical treatments.

Market Drivers

The growth of direct-to-consumer e-commerce platforms and the rising uptake of personalized treatment plans are fundamentally transforming market accessibility. By utilizing telemedicine services, companies can now deliver customized nutraceuticals and prescription-strength hair loss solutions directly to consumers, helping to minimize the stigma often attached to seeking treatment. This approach promotes high customer retention through subscription models tailored to individual physiological requirements, effectively expanding the market reach. As evidence of this trend, Hims & Hers Health, Inc. reported in their 'Third Quarter 2024 Financial Results' in November 2024 that their subscriber base had reached a record 2.0 million, a milestone largely driven by the appetite for personalized health solutions, confirming a shift toward digital health management where convenience drives adherence.

Simultaneously, the market is being propelled by technological breakthroughs in non-invasive restoration and the development of novel pharmaceutical agents that target previously unmet medical needs. The industry is increasingly adopting sophisticated immunomodulatory and biotechnology-based treatments, specifically for autoimmune disorders such as alopecia areata, supported by venture capital funding dedicated to bringing these mechanisms to market.

For example, Pelage Pharmaceuticals announced in a February 2024 press release titled 'Pelage Pharmaceuticals Announces $16.75 Million Series A Financing' that it had secured funding to develop PP405, a topical treatment aimed at reactivating dormant hair follicle stem cells. These investments are further validated by regulatory successes, such as the U.S. FDA's 2024 approval of Sun Pharmaceutical Industries Ltd.'s LEQSELVI for severe alopecia areata, which has significantly broadened the available therapeutic options.

Market Challenges

Rigorous regulatory mandates regarding novel pharmaceutical agents represent a major hurdle for the Global Hair Growth Supplement and Treatment Market. Regulatory bodies enforce strict testing protocols to ensure both safety and efficacy, a process that inevitably extends the development timeline for new clinical therapies. This protracted approval phase creates a gap between the speed of innovation and actual market availability, compelling companies to sustain long periods of capital spending without generating revenue. Consequently, the launch of advanced formulations is often postponed, restricting the industry's capacity to debut next-generation therapies that could otherwise enhance market valuation.

This regulatory bottleneck is particularly constraining given the rapidly increasing number of individuals seeking restoration services. According to the International Society of Hair Restoration Surgery, the average patient volume per member physician rose by 20% in 2024 compared to 2021 levels, indicating a strong desire for effective treatments. However, because regulatory slowdowns hinder the market from fully capitalizing on this demand with new pharmaceutical solutions, the industry finds it difficult to immediately translate this heightened consumer interest into revenue through advanced product introductions.

Market Trends

The market is experiencing a notable rise in clean label, vegan, and plant-based formulations as consumers increasingly value holistic wellness and safety over synthetic pharmacotherapy. This preference is prompting the reformulation of hair health products to eliminate artificial additives and hormones, utilizing standardized botanicals instead to address root causes such as stress without causing adverse side effects. The success of this shift toward drug-free efficacy is demonstrated by the enduring performance of major natural brands; for instance, Unilever's 'What's behind Unilever's first half results?' report from August 2025 noted that its Wellbeing business group, led by the plant-based brand Nutrafol, achieved strong double-digit growth for the 21st consecutive quarter, underscoring the demand for nature-derived, scientifically validated solutions.

In parallel, the widespread availability of clinical-grade at-home hair growth devices is democratizing access to advanced restoration therapies that were once limited to professional clinics. Technological miniaturization has facilitated the mass production of sophisticated LED and low-level laser therapy (LLLT) wearables, providing users with professional-level results alongside the convenience of autonomous use. This sector is growing rapidly as consumers look for cost-effective, non-invasive alternatives to long-term medication or surgical procedures. According to an article by The Industry.beauty in September 2025 titled 'Beauty Tech Group targets £320m valuation ahead of stock market debut', the Beauty Tech Group saw sales increase by 27% to £55.2 million in the first half of 2025, a growth spur fueled by the rising global adoption of its at-home hair restoration devices.

Key Players Profiled in the Hair Growth Supplement and Treatment Market

• Nutraceutical Wellness Inc.
• Viviscal Limited.
• GNC Holdings, Inc.
• Procter & Gamble
• InVite Health
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Curallux, LLC.
• iRestore Hair Growth System
• Lexington International, LLC

Report Scope

In this report, the Global Hair Growth Supplement and Treatment Market has been segmented into the following categories:

Hair Growth Supplement and Treatment Market, by Type:

• Supplements
• Pharmaceuticals
• Devices

Hair Growth Supplement and Treatment Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hair Growth Supplement and Treatment Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.